Super Religare Laboratories buys Piramal Diagnostic for $129M

In a deal that will make them the largest laboratory services provider in India, Super Religare Laboratories agreed to buy Mumbai-based Piramal Diagnostic for 6 billion rupees ($129 million). The united company will serve more than 12 million customers with its 170 labs, Bloomberg notes. Piramal brings a larger focus on medical imaging to Super Religare, which had previously set its sights on pathology services.

"This combination will go a long way in changing the diagnostic services landscape of not just India but also the Asia region," says Ajay Piramal, chairman of Piramal, in a statement. Piramal believes India's diagnostic market will grow from an estimated worth of 120 billion rupees today by as much as 24 percent annually. The company's stock fell slightly, by 1.5 percent, after the announcement.

- get the Piramal announcement
- read the Bloomberg article
- check out The Wall Street Journal's coverage

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.